Large gap with delayed quotes
Analysis date: 03.03.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 27.02.2026.
Interest
Weak
Weak
Two stars since 03.03.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 06.02.2026 at a price of 191.35.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 13.01.2026.
4wk Rel Perf
1.30%
1.30%
The four-week dividend-adjusted overperformance versus SP500 is 1.30%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 27.02.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.70%.
Mkt Cap in $bn
180.79
180.79
With a market capitalization >$8bn, SALESFORCE is considered a large-cap stock.
G/PE Ratio
0.89
0.89
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
13.34
13.34
The estimated PE is for the year 2028.
LT Growth
11.12%
11.12%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
48
48
Over the last seven weeks, an average of 48 analysts provided earnings per share estimates.
Dividend Yield
0.80%
0.80%
The twelve month estimated dividend yield represents 10.66% of earnings forecasts.
Beta
107
107
For 1% of index variation, the stock varies on average by 1.07%.
Correlation
0.56
0.56
56.34% of stock movements are explained by index variations.
Value at Risk
23.60
23.60
The value at risk is estimated at USD 23.60. The risk is therefore 12.04%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
17.11.2004
17.11.2004